Increased Lactate Release per Fat Cell in Normoglycemic First-Degree Relatives of Individuals with Type 2 Diabetes

Diabetes

Volumn 50, Issue 10, 2001, Pages 2344-2348

  Sandqvist, Madeléne M ^a   Eriksson, Jan W ^b   Jansson, Per Anders E ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID;

ABDOMEN; ADIPOCYTE; ADULT; ARTICLE; DIET RESTRICTION; FEMALE; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINISM; MALE; METABOLISM; MICRODIALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; REFERENCE VALUE;

ABDOMEN; ADIPOCYTES; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; LACTIC ACID; MALE; MICRODIALYSIS; REFERENCE VALUES;

EID: 0035491322     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.10.2344     Document Type: Article

References (58)

1. Haffner S, Stern M, Hazuda H, Pugh J, Patterson J: Hyperinusulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med 315:220-224, 1986
2. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
3. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in developement of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925-929, 1992
4. Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA: The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41:1575-1586, 1992
5. Perseghin G, Ghosh S, Gerow K, Shulman GI: Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001-1009, 1997
6. O'Rahilly S, Turner R, Matthews D: Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 18:1225-1230, 1988
7. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Järvinen H, Evron W, Dailey G, Gerich J: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 273:1855-1861, 1995
8. Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782-788, 1992
9. Eriksson JW, Smith U, Waagstein F, Wysocki M, Jansson P-A: Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes 48:1572-1578, 1999
10. Axelsen M, Smith U, Eriksson JW, Taskinen MR, Jansson P-A: Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes. Ann Intern Med 131:27-31, 1099
11. Ohlson LO, Larsson B, Björntorp P, Eriksson H, Svärdsudd K, Welin L, Tibblin G, Wilhelmsen L: Risk factors for type 2 (non-insulin-dependent) diabetes mellitus: thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 31:798-805, 1988
12. Barnett AH, Spiliopoulos AJ, Pyke DA, Stubbs WA, Burrin J, Alberti KGMM: Metabolic studies in unaffected co-twins of non-insulin-dependent diabetics. Br Med J (Clin Res Ed) 282:1656-1658, 1981
13. Osei K, Cottrell DA, Bossetti B: Relationships of obesity indices to serum insulin and lipoproteins in relatives of black patients with noninsulin-dependent diabetes mellitus (NIDDM). Int J Obes 15:441-451, 1991
14. Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M: Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited: metabolic studies on offspring of diabetic probands. J Clin Invest 101:86-96, 1998
15. Lovejoy J, Mellen B, Digirolamo M: Lactate generation following glucose ingestion: relation to obesity, carbohydrate tolerance and insulin sensitivity. Int J Obes 14:843-855, 1990
16. Jansson P-A, Larsson A, Smith U, Lönnroth P: Lactate release from the subcutaneous tissue in lean and obese men. J Clin Invest 93:240-246, 1994
17. Jansson PA, Smith U, Lönnroth P: Evidence for lactate production by human adipose tissue in vivo. Diabetologia 33:253-256, 1990
18. Hagström E, Arner P, Ungerstedt U, Bolinder J: Subcutaneous adipose tissue: a source of lactate production after glucose ingestion in humans. Am J Physiol 258:E888-E893, 1990
19. Frayn KN, Coppack SW, Humphreys SM, Whyte PL: Metabolic characteristics of human adipose tissue in vivo. Clin Sci 76:509-516, 1989
20. Kashiwagi A, Verso MA, Andrews J, Vasques G, Reaven G, Foley JE: In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus. J Clin Invest 72:1246-1254, 1983
21. Mårin P, Rebuffé-Scrive M, Smith U, Björntorp P: Glucose uptake in human adipose tissue. Metabolism 36:1154-1160, 1987
22. Consoli A, Nurjahan N, Reilly JJ, Bier DM, Gerich JE: Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus: role of alterations in systemic, hepatic and muscle lactate and alanine metabolism. J Clin Invest 86:2038-2045, 1990
23. Pearce FJ, Connett RJ: Effect of lactate and palmitate on substrate utilization of isolated rat soleus. Am J Physiol 238:C149-C159, 1980
24. Federspil G, Zaccaria M, Pedrazzoli S, Zago E, DePalo C, Sandellari C: Effects of sodium BL-lactate on insulin secretion in anesthetized dogs. Diabetes 29:33-36, 1980
25. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA: Validation of a tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 60:1327-1332, 1986
26. Smith U, Sjöström L, Björntorp P: Comparison of two methods for determining human adipose cell size. J Lipid Res 13:822-824, 1972
27. Lönnroth P, Jansson P-A, Smith U: A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 253:E228-E231, 1987
28. Larsen OA, Lassen NA, Quaade F: Blood flow through human adipose tissue determined with radioactive xenon. Acta Physiol Scand 66:337-345, 1966
29. 133Xenon. Scand J Clin Lab Invest 29:31-36, 1972
30. 3 in human subcutaneous adipose tissue. Univ Lund Dept Anat Commun 6:1-9, 1960
31. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissen M, Ehrnstrom BO, Forsen B, Isomaa B, Snickars B, Taskinen MR: Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585-1593, 1996
32. Carvalho E, Jansson P-A, Nagaev I, Wenthzel A-M, Smith U: Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB J 15:1101-1103, 2001
33. DiGirolamo M, Newby D, Lovejoy J: Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J 6:2405-2412, 1992
34. Landau BR, Wahren J: Nonproductive exchanges: the use of isotopes gone astray. Metabolism 41:457-459, 1992
35. Jansson P-A, Smith U, Lönnroth P: Microdialysis assessment of adipose tissue metabolism in post-absorptive obese NIDDM subjects. Eur J Clin Invest 25:584-589, 1095
36. DiGirolamo M, Skinner NS Jr, Hanley HG, Sachs RG: Relationship of adipose tissue blood flow to fat cell size and number. Am J Physiol 220:932-937, 1971
37. Krotkiewski M, Blohme B, Lindholm N, Björntorp P: The effects of adrenal glucocorticoids on regional adipocyte size in man. J Clin Endocrinol Metab 42:91-97, 1976
38. Bonnet F, Vanderschueren-Lodeweyckx M, Eeckels R, Malvaux P: Subcutaneous adipose tissue and lipids in blood in growth hormone deficiency before and after treatment with human growth hormone. Pediatr Res 8:800-805, 1974
39. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T: Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41:1257-1266, 1992
40. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Nagai R, Tobe K, Kimura S, Kadowaki T: PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4:597-609, 1999
41. Danforth E Jr: Failure of adipocyte differentiation causes type 2 diabetes mellitus (Letter)? Nat Med 26:13, 2000
42. Spiegelman BM: PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514, 1998
43. Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus-Samuels B, Feigenbaum L, Lee E, Aoyama T, Eckhaus M, Reitman ML, Vinson C: Life without white fat: a transgenic mouse. Genes Dev 12:3175-3180, 1998
44. Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL, Vinson C, Eckhaus M, Reitman ML: Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105:271-278, 2000
45. McGarry JD, Dobbins RL: Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42:128-138, 1999
46. Holmäng A, Nilsson C, Niklasson M, Larsson BM, Lönnroth P: Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin. Diabetes 48:106-111, 1999
47. Yki-Järvinen H, Bogardus C, Foley JE: Regulation of plasma lactate concentration in resting human subjects. Metabolism 39:859-864, 1990
48. Gelding SV, Coldham N, Niththyananthan R, Anyaoku V, Johnston DG: Insulin resistance with respect to lipolysis in non-diabetic relatives of European patients with type 2 diabetes. Diabet Med 12:66-73, 1995
49. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72:96-107, 1991
50. Campbell PJ, Carlson MG: Impact of obesity on insulin action in NIDDM. Diabetes 42:405-410, 1993
51. Mohammed-Ali V, Pinkey JH, Coppack SW: Adipose tissue as an endocrine and paracrine organ. Int J Obes 22:1145-1158, 1998
52. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
53. Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286-1292, 1997
54. Fried SK, Bunkin DA, Greenberg AS: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847-850, 1998
55. Peraldi P, Spiegelman B: TNF-alpha and insulin resistance: summary and future prospects. Mol Cell Biochem 182:169-175, 1998
56. Kim JK, Michael MD, Previs SF, Peroni OD, Mauvais-Jarvis F, Neschen S, Kahn BB, Shulman GI: Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest 105:1791-1797, 2000
57. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i:785-789, 1963
58. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE: Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43:1498-1506, 2000